TyG is considered as a novel indicator of IR, but previous study found that a significant number patients with fatty liver remained insulin sensitive and 37% of these patients presented no metabolic syndrome, prediabetes or diabetes (55). The gene discussed is INS; the disease is metabolic syndrome.